Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link

Bibliographic Details
Main Author: Claudio Jommi
Format: Article
Language:English
Published: AboutScience Srl 2015-09-01
Series:Global & Regional Health Technology Assessment
Online Access:https://journals.aboutscience.eu/index.php/grhta/article/view/336
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://journals.aboutscience.eu/index.php/grhta/article/view/336

Similar Items

  • Shortage of plasma-derived medicinal products: what is next? narrative literature review on its causes and counteracting policies in Italy
    by: Matteo Bolcato, et al.
    Published: (2024-05-01)
  • Management of patients eligible for proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: economic impact and reform proposals
    by: Claudio Jommi, et al.
    Published: (2019-07-01)

  • by: Carlo Lucioni, et al.
    Published: (2019-11-01)

  • by: Claudio Jommi, et al.
    Published: (2019-07-01)
  • The value of obinutuzumab for untreated advanced Follicular Lymphoma: an assessment based on Multicriteria Decision Analysis (MCDA)
    by: Claudio Jommi, et al.
    Published: (2019-11-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs